For the HER-1 immunosensor, the clinical samples might need to be diluted to match the linear range of the AuNP-conjugate sensor (HER-1 serum concentration range for healthy patients is between 1.0 and 25 ng mL−1 and it is higher in breast cancer patients). The gene discussed is EGFR; the disease is breast carcinoma.